Skip to content
Open access · CC-BY via OpenAlex

Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness

Nengzhi Pang, Jinping He, Lei Pei, Ying Xiao, Yingying Gu, Cheng Zhi, Xuye Lai, Mingtao Chen, Qiyao Xiao, Xueqian Wu, Zhenfeng Zhang, Lili Yang

Molecular Therapy · 2026 · ▲ 3 citations

Abstract

differentiation, in part through a transcriptional program associated with Foxo1, thereby improving the efficacy of ACT. These findings identify NR as a promising and translatable metabolic adjuvant for HCC immunotherapy.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ymthe.2026.05.026
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Pang, N., He, J., Pei, L., Xiao, Y., Gu, Y., Zhi, C., Lai, X., Chen, M., Xiao, Q., Wu, X., Zhang, Z., &amp; Yang, L. (2026). Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness. <em>Molecular Therapy</em>. https://doi.org/10.1016/j.ymthe.2026.05.026
Vancouver
Pang N, He J, Pei L, Xiao Y, Gu Y, Zhi C, et al. Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.05.026.
BibTeX
@article{nengzhi2026Nicoti, title = {Nicotinamide riboside enhances adoptive T cell therapy by promoting memory differentiation and metabolic fitness}, author = {Nengzhi Pang and Jinping He and Lei Pei and Ying Xiao and Yingying Gu and Cheng Zhi and Xuye Lai and Mingtao Chen and Qiyao Xiao and Xueqian Wu and Zhenfeng Zhang and Lili Yang}, journal = {Molecular Therapy}, year = {2026}, doi = {10.1016/j.ymthe.2026.05.026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings